2 nd Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

10
2 nd Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD Modular PMA Updates Thinh Nguyen CDRH/ODE

description

2 nd Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD. Modular PMA Updates. Thinh Nguyen CDRH/ODE. Modular PMA Guidance. Revisions: Panel track supplements, i.e., those with pre-clinical data, may be submitted as modular PMA - PowerPoint PPT Presentation

Transcript of 2 nd Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Page 1: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

2nd Annual CDRH/CBER Stakeholder MeetingNovember 18, 2004Gaithersburg, MD

Modular PMA Updates

Thinh Nguyen

CDRH/ODE

Page 2: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular PMA Guidance

Revisions:Panel track supplements, i.e., those with pre-

clinical data, may be submitted as modular PMA

Modules may be submitted at the same time if acceptable to review division

Page 3: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular PMA Data FY 00 - FY 03Number of Modules Received

86

80

83

73

6668707274767880828486

Nu

mb

er

of

Mo

du

les

FY 00 FY 01 FY 02 FY 03

Fiscal Year

Page 4: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular PMA Data FY 00 - FY 03Avg. Review Time Per Cycle

130 123

104

127

0

20

40

60

80

100

120

140

Avg

. R

evie

w T

ime (

FD

A

Days)

FY 00 FY 01 FY 02 FY 03

Fiscal Year

Page 5: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular PMA Data FY 00 - FY 03Avg. # of Review Cycles

1.3 1.3 1.31.2

0

1

2

Avg

. R

evie

w C

ycle

FY 00 FY 01 FY 02 FY 03

Fiscal Year

Page 6: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular Data FY 00 – FY 03

91 92107

138

185

9195

122

180

258

90 91

115

135

196

114129 135

182

220

0

50

100

150

200

250

300

Nu

mb

er

of

FD

A D

ays

FY 00 FY 01 FY 02 FY 03

Percentile

50%

60%

70%

80%

90%

Page 7: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular Data FY 00 – FY 03

Number of modules are decreasing (per FDA guidance document)

Modules are more complex (e.g., pre-clinical vs. biocompatibility)

Wide variability in the number of review days Review time is unpredictable

Page 8: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Proposed Performance GoalOption #1 The following cycle goal will applied:

For FY 06, 70% of the modules received will have an action taken within 120 days for each review cycle

For FY 07, 80% of the modules received will have an action taken within 120 days for each review cycle

Advantage – More predictabilityDisadvantage – Longer review time

Page 9: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Proposed Performance GoalOption #2 The following cycle goal will applied:

For FY 06, 50% of the modules received will have an action taken within 90 days for each review cycle

For FY 07, 60% of the modules received will have an action taken within 90 days for each review cycle

Advantage – Shorter review timeDisadvantage – Less predictability

Page 10: 2 nd  Annual CDRH/CBER Stakeholder Meeting November 18, 2004 Gaithersburg, MD

Modular Performance Goal

Other Options? Submit to MDUFMA Docket